Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna Neuberg

Showing results (181-190 of 354) with videos related to

Pageof 36
Sort By:
British Journal of Haematology|February 6, 2016
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experienceDaniel L Van Dyke, Lillian Werner, Laura Z Rassenti, et al.
Leukemia Research|August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) studyAthena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortiumDanelle F James, Lillian Werner, Jennifer R Brown, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Pediatric Blood & Cancer|April 14, 2011
Long-term clinical outcomes following treatment of childhood craniopharyngiomaKaren M Winkfield, Henry K Tsai, Xiaopan Yao, et al.
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Leukemia & Lymphoma|July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphomaEric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Pageof 36

Showing results (181-190 of 354) with videos related to

Sort By:
Pageof 36
British Journal of Haematology|February 6, 2016
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experienceDaniel L Van Dyke, Lillian Werner, Laura Z Rassenti, et al.
Leukemia Research|August 19, 2003
Comparison of interphase FISH and metaphase cytogenetics to study myelodysplastic syndrome: an Eastern Cooperative Oncology Group (ECOG) studyAthena M Cherry, Stephanie R Brockman, Sarah F Paternoster, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 29, 2014
Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortiumDanelle F James, Lillian Werner, Jennifer R Brown, et al.
Experimental Hematology|February 26, 2005
Failure to define window of time for autologous tumor vaccination in patients with newly diagnosed or relapsed acute lymphoblastic leukemiaW Nicholas Haining, Angelo A Cardoso, Heather L Keczkemethy, et al.
Pediatric Blood & Cancer|April 14, 2011
Long-term clinical outcomes following treatment of childhood craniopharyngiomaKaren M Winkfield, Henry K Tsai, Xiaopan Yao, et al.
Elife|July 24, 2013
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancyStefan Heinrichs, Lillian F Conover, Carlos E Bueso-Ramos, et al.
Leukemia & Lymphoma|July 12, 2014
Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphomaEric Jacobsen, Olga Pozdnyakova, Robert Redd, et al.
Haematologica|November 13, 2012
Everolimus in combination with rituximab induces complete responses in heavily pretreated diffuse large B-cell lymphomaJeffrey A Barnes, Eric Jacobsen, Yang Feng, et al.
Blood Advances|January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell diseaseJoshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
Leukemia Research|December 28, 2022
Intensity of induction regimen and outcomes among adults with Ph+ALL undergoing allogeneic hematopoietic stem cell transplantationHari S Raman, Se Eun Kim, Daniel J DeAngelo, et al.
Pageof 36